Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial.
Saved in:
| Title: | Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial. |
|---|---|
| Authors: | Biganzoli G; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Isnaldi E; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Richard F; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Marano G; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Boracchi P; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy., Maetens M; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Floris G; KU Leuven, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, Leuven, Belgium; University Hospitals Leuven, Department of Pathology, Leuven, Belgium., Neven P; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium., Jerusalem G; Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium., Munzone E; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Hitre E; Department of Medical Oncology and Clinical Pharmacology 'B', National Institute of Oncology, Budapest, Hungary., Gombos A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Thompson A; Division of Surgical Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, USA., Aebi S; Division of Medical Oncology, Cancer Center, Lucerne Cantonal, Hospital, Lucerne, Switzerland; Faculty of Medicine, University of Bern, Bern, Switzerland., Kammler R; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland., Dell'Orto P; IBCSG Central Pathology Office, Milan, Italy., Viale G; IBCSG Central Pathology Office, Milan, Italy; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy., Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Colleoni M; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy., Biganzoli E; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium., Desmedt C; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium. Electronic address: christine.desmedt@kuleuven.be. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Jun 03; Vol. 222, pp. 115438. Date of Electronic Publication: 2025 Apr 17. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40286474 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Biganzoli+G%22">Biganzoli G</searchLink>; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Isnaldi+E%22">Isnaldi E</searchLink>; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Richard+F%22">Richard F</searchLink>; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Marano+G%22">Marano G</searchLink>; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Boracchi+P%22">Boracchi P</searchLink>; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Maetens+M%22">Maetens M</searchLink>; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Floris+G%22">Floris G</searchLink>; KU Leuven, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, Leuven, Belgium; University Hospitals Leuven, Department of Pathology, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Neven+P%22">Neven P</searchLink>; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Jerusalem+G%22">Jerusalem G</searchLink>; Medical Oncology Department, CHU Liège, Liège University, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Munzone+E%22">Munzone E</searchLink>; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Hitre+E%22">Hitre E</searchLink>; Department of Medical Oncology and Clinical Pharmacology 'B', National Institute of Oncology, Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22Gombos+A%22">Gombos A</searchLink>; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Thompson+A%22">Thompson A</searchLink>; Division of Surgical Oncology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Aebi+S%22">Aebi S</searchLink>; Division of Medical Oncology, Cancer Center, Lucerne Cantonal, Hospital, Lucerne, Switzerland; Faculty of Medicine, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kammler+R%22">Kammler R</searchLink>; Translational Research Coordination, ETOP IBCSG Partners Foundation, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dell'Orto+P%22">Dell'Orto P</searchLink>; IBCSG Central Pathology Office, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Viale+G%22">Viale G</searchLink>; IBCSG Central Pathology Office, Milan, Italy; Department of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Regan+MM%22">Regan MM</searchLink>; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Colleoni+M%22">Colleoni M</searchLink>; Division of Medical Senology, IEO European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Biganzoli+E%22">Biganzoli E</searchLink>; Unit of Medical Statistics, Biometry and Epidemiology, Department of Biomedical and Clinical Sciences (DIBIC) 'L. Sacco' & DSRC, LITA Vialba campus, University of Milan, Milan, Italy; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Desmedt+C%22">Desmedt C</searchLink>; KU Leuven, Department of Oncology, Laboratory for Translational Breast Cancer Research, Leuven, Belgium. Electronic address: christine.desmedt@kuleuven.be. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2025 Jun 03; Vol. 222, pp. 115438. <i>Date of Electronic Publication: </i>2025 Apr 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40286474 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2025.115438 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 115438 Titles: – TitleFull: Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Biganzoli G – PersonEntity: Name: NameFull: Isnaldi E – PersonEntity: Name: NameFull: Richard F – PersonEntity: Name: NameFull: Marano G – PersonEntity: Name: NameFull: Boracchi P – PersonEntity: Name: NameFull: Maetens M – PersonEntity: Name: NameFull: Floris G – PersonEntity: Name: NameFull: Neven P – PersonEntity: Name: NameFull: Jerusalem G – PersonEntity: Name: NameFull: Munzone E – PersonEntity: Name: NameFull: Hitre E – PersonEntity: Name: NameFull: Gombos A – PersonEntity: Name: NameFull: Thompson A – PersonEntity: Name: NameFull: Aebi S – PersonEntity: Name: NameFull: Kammler R – PersonEntity: Name: NameFull: Dell'Orto P – PersonEntity: Name: NameFull: Viale G – PersonEntity: Name: NameFull: Regan MM – PersonEntity: Name: NameFull: Colleoni M – PersonEntity: Name: NameFull: Biganzoli E – PersonEntity: Name: NameFull: Desmedt C IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2025 Jun 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 222 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |
